ResMed Inc. (RMD) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diag...
ResMed Inc. (RMD) currently trades at a P/E ratio of 22.82 (historical range: 17.61–42.36, median: 28.53), placing it at the 23th percentile — below its historical average, P/S ratio of 6.26 (range: 4.83–9.00, 23th percentile — below its historical average), EV/EBITDA of 23.42 (range: 17.92–98.23, 26th percentile).
Over the historical period (2024-08-30 to 2026-08-28), ResMed Inc.'s P/E ratio has contracted by 37% over the observed period (from an average of 37.1 to 23.5).
ResMed Inc. appears significantly undervalued relative to its historical range, trading at depressed multiples across most metrics.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 22.82 | 17.61 | 28.53 | 42.36 | 23th | below its historical average |
| P/S Ratio | 6.26 | 4.83 | 7.60 | 9.00 | 23th | below its historical average |
| EV/EBITDA | 23.42 | 17.92 | 37.99 | 98.23 | 26th | below its historical average |
| FCF Yield | 0.04 | 0.01 | 0.02 | 0.05 | 63th | below its historical average |